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Treatment of spinal cord injury (SCI) remains challenging. Considering
the rapid developments in neurorestorative therapies for SCI, we have
revised and updated the Clinical Therapeutic Guidelines for
Neurorestoration in Spinal Cord Injury (2016 Chinese version) of the Chinese
Association of Neurorestoratology (Preparatory) and China Committee
of International Association of Neurorestoratology. Treatment of SCI is a
systematic multimodal process that aims to improve survival and restore
neurological function. These guidelines cover real‐world comprehensive
neurorestorative management of acute, subacute, and chronic SCI and
include assessment and diagnosis, pre‐hospital first aid, treatment,
rehabilitation, and complication management.
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1

Introduction

Spinal cord injury (SCI) can result in acute
edema or hemorrhagic contusion and cause
motor, sensory, and autonomic neurological
dysfunction below the level of injury [1]. SCI
imposes a heavy public health burden [2–4].
According to incomplete statistics, there are
more than one million patients with SCI in
China and the number is growing by 120,000 per
year [5–8]. Disability and mortality related to
SCI have been significantly decreased because of
effective pre‐hospital emergency care, progress
in clinical treatment, and improved nursing
techniques. Furthermore, various effective
neurorestorative treatment strategies are now
being widely used [9–13]. In view of the rapid
developments in neurorestorative therapy for
SCI, the Chinese Association of Neurores‐
toratology (Preparatory) and China Committee
of International Association of Neurores‐
toratology revised and updated the Clinical
Therapeutic Guidelines for Neurorestoration in SCI
in 2016 [14]. SCI can be divided into four stages
according to time: acute (< 48 h), subacute (48 h
–14 d), intermediate (14 d–6 months), and
chronic (> 6 months) [15]. The guidelines
presented here are based on evidence published
before 31 December, 2020. Although the methods
in the guidelines can restore neurologic function
in SCI patients to a certain extent, complete
recovery from severe SCI remains difficult.

2
2.1

Acute and subacute stages of SCI
Assessment

SCI patients should undergo a thorough
neurological examination as early as possible to
assess severity and prognosis as well as a
comprehensive physical examination to rule out
associated injuries [16, 17]. The International
Standards for Neurologic Classification of SCI

(ISNCSCI) is the most widely accepted classifica‐
tion system for sensorimotor impairment [18–20].
The American Spinal Injury Association (ASIA)
neurological score is the most widely used
quantitative neurological assessment. Quality of
life is evaluated using the International Associa‐
tion of Neurorestoratology SCI Functional
Rating Scale [14, 15].
2.2

Imaging examination

Radiography may miss spinal fracture and is not
recommended as the modality of choice for
cervical spine injury [21]. However, anterior–
posterior and lateral views should be obtained
when used, which can demonstrate vertebral
alignment and type of fracture or dislocation.
Computed tomography (CT) is the most
commonly used imaging modality to diagnose
spinal fracture or dislocation [22]. Axial and
three‐ dimensional views can show the shape of
the spinal canal and facet joints and can detect
small and hidden lesions missed by plain
radiography [21, 22].
Magnetic resonance imaging (MRI) is the
modality of choice to evaluate the integrity,
injury site, severity, and involvement of the
intervertebral disc, ligaments, spinal cord, cauda
equina, and nerve roots [23]. MRI can show
displaced disk fragments and ligamentous
injury as well as spinal cord edema and
hemorrhage on T2‐weighted sequences [24].
Range of hemorrhage and edema and degree of
spinal cord compression on MRI are associated
with neurological prognosis [25, 26]. Evaluation
of both preoperative and postoperative MRI is
more helpful in predicting neurological outcome
[27]. In addition to conventional sequences, new
quantitative MRI techniques such as diffusion
tensor imaging can reflect microscopic patho‐
logical changes in spinal white matter by
detecting diffusion direction and dispersion of
water molecules. MRI accurately evaluates SCI
Journal of Neurorestoratology
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to guide classification and surgical treatment [23,
28–30].
2.3

Diagnosis

The diagnosis of SCI should include the injured
level, severity of injury, type of vertebral fracture
and/or dislocation, and stability of the spine.
Severity of SCI is currently classified according
to the ASIA Impairment Scale (AIS) [18, 20].
Grade A is a complete injury, with no sensory or
motor function preservation in S4 and S5. Grade
B is an incomplete injury with preservation of
sensory but not motor function below the level
of injury, including S4 and S5; no motor function
is preserved more than three levels below on
either side of the body. Grade C is also an
incomplete injury but motor function is
preserved below the level of injury with more
than half of the key muscles below graded less
than 3 on manual muscle testing. In grade D, at
least half of the key muscles below are graded 3
or more. Grade E indicates normal neurological
function or function unchanged compared to
before the injury.
2.4

Treatments

In addition to treatment of the primary injury,
secondary SCI requires attention [9, 14–16]. The
main purpose of SCI treatment is to reduce
secondary injury in the acute and subacute
stages. Treatments include early reduction and
fixation, complete decompression, cell therapy,
early rehabilitation, and prevention of complica‐
tions [5, 16, 31–33].
2.4.1

Pre‐hospital aid

Appropriate pre‐hospital emergency treatment
is important to reduce mortality and improve
outcomes. Neurorestorative treatments require
close cooperation between treating specialists.
Regional spinal cord injury centers with a
specialized multidisciplinary SCI team compris‐
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ing representatives from emergency medicine,
orthopedics, neurosurgery, general surgery,
intensive care medicine, radiology, neurology,
anesthesiology, and others should be established
[34–38].
After trauma, emergency personnel should
evaluate the patient quickly and stabilize the
head and entire spine to prevent secondary
injury. Three or more people should be utilized
to lift and move the patient to a flat plate or
special stretcher and transport them to a
qualified hospital by ambulance or helicopter [5,
37]. Life support (airway, breathing and
circulation) should be provided when necessary
[39]. Telehealth communications can be used to
inform hospital personnel of impending arrival
and receive medical direction in transport. After
admission, a multidisciplinary team should
evaluate the patient, determine injuries and their
severity, and initiate immediate treatment. Use
of multidisciplinary teams reduces mortality
and length of hospital stay [40].
2.4.2

Drug therapy

Early high‐dose methylprednisolone (MP) has
been considered to improve SCI prognosis [41].
However, the National Acute SCI Studies I and
II in the United States showed only moderate
efficacy with possibly serious complications. MP
has not been recommended in the guidelines of
the American Association of Neurosurgeons
(AANS) and the Congress of Neurological
Surgeons (CNS) since 2013. The current
consensus is that evidence for use of high‐dose
MP in SCI is insufficient [42] and it is no longer
routinely recommended because of complica‐
tions such as respiratory system infection,
gastrointestinal bleeding, arrhythmia, and even
death. However, it remains an option in selected
cases [11, 42–45]. In 2017, AOSpine recom‐
mended MP as a treatment option for patients
within 8 h of acute SCI [46].
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When MP is elected, attention should be paid to
the following points:
a) The time window for use is < 8 h from
injury. Administration should proceed as
follows: 30 mg/kg initial intravenous bolus
within 15 min, a pause of 45 min, followed by
maintenance continuous infusion at 5.4 mg/(k∙h)
for 23 h [41].
b) To reduce the risk of side effects, MP
should be stopped as soon as possible in
patients whose neurological symptoms have
resolved.
c) Contraindications to high‐dose MP are as
follows: spinal injury without neurological dys‐
function, discontinuity of the spinal cord, > 8 h
after injury, gastrointestinal bleeding, gunshot
SCI, elderly patients with high risk of
pneumonia, and diabetic patients.
Although the combination of ganglioside
(100 mg/d) and MP can improve outcome in
early acute SCI [47], Guillain–Barre syndrome
has been reported after ganglioside use. The
development of antibodies secondary to
exogenous gangliosides significantly increases
the probability of Guillain–Barre syndrome [48,
49]. Therefore, ganglioside is not currently
recommended for routine use in SCI. Large
clinical trials are needed fully determine
ganglioside efficacy [45, 46, 50].
Other drugs, including erythropoietin, riluzole,
minocycline, sex hormone, neurotrophic factor,
sodium aescinate, axonal growth promoting
agent, granulocyte colony stimulating factor,
magnesium agent, and fibroblast growth factor
[2] are in clinical trials or have been in clinical
use, but high‐level evidence to support their
routine use is lacking [15, 45, 51–53]. Although
intravenous vasopressor agents such as
norepinephrine can improve local spinal cord
perfusion pressure and hemodynamics after SCI
[54–56], their effect on neurological recovery is
uncertain. Furthermore, they may be associated

with increased risk of adverse events, pre‐
dominantly cardiac [56, 57].
2.4.3

Hypothermia therapy

The purpose of hypothermia treatment is to
reduce the basic metabolic rate of the central
nervous system, reduce energy consumption of
the spinal cord, and alleviate the energy supply
disorder caused by spinal cord ischemia and
hypoxia [58]. Induction of systemic hypothermia
to a temperature between 32 ℃ and 34 ℃ seems
to be most effective [58–66]. Local hypothermia
is also effective [64–66], which can be achieved
using epidural or subdural coolant (6 ℃) [62]
infused via an open or closed system. So, far,
there is no recognized indication or contrain‐
dication for hypothermia treatment in acute SCI.
If medical and patient conditions permit,
systemic and local hypothermia treatment
should be carried out at the same time [62–64].
2.4.4

Surgery

Early decompression and stabilization
Early spinal cord decompression and spinal
stabilization are the basic treatment principles of
SCI [67]. It is safe to perform emergency spinal
reduction and stabilization during the acute
phase, which can improve neurological outcome,
shorten hospitalization time, and reduce
complications. Emergency spinal cord decom‐
pression can reduce secondary injury, preserve
neurological function of surviving axons, and
prevent further spinal cord damage. Spinal cord
compartment syndrome (SCCS) after severe
acute SCI, similar to osteofascial compartment
syndrome, has been proposed as a mechanism
of secondary injury [37, 38, 68–72]. This theory
hypothesizes that spinal cord ischemia, edema,
contusion, and laceration along with bony
compression of the spinal canal increases
intradural
spinal
pressure,
aggravating
secondary injury via ischemia, edema and
Journal of Neurorestoratology
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degeneration necrosis in a vicious cycle [69–71,
73]. An alternative term for SCCS is spinal cord
intramedullary hypertension (SCImH).
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Decompression and internal fixation should be
performed as early as possible (< 24 h) in
patients with obvious neurological dysfunction,
whether the injury is complete (AIS A) or
incomplete (AIS B–D) [37, 73–75]. The idea that
“time is spine” has been widely recognized [38,
68, 74–87]. In 2017, AOSpine guidelines
recommended that when the acute SCI patient is
stable, surgery should be performed within 24 h
of injury, whether complete or incomplete [77].
However, due to the problems of patient
transport and need for preoperative examina‐
tion and preparation, this cannot be achieved in
many patients. Nonetheless, other studies have
shown that surgical intervention within 3 days
for SCI can provide benefit, with greater benefit
associated with earlier surgical treatment [78–80,
85, 87]. Therefore, surgery should be performed
as early as possible and within 3 days of injury
in patients who cannot undergo surgery within
24 h [67]. In particular, patients with cervical SCI
need to be thoroughly assessed, especially for
lung injury and smoking history. Postoperative
risk of infection and respiratory failure is
increased in patients with unstable vital signs
before surgery, which can result in a difficult
postoperative clinical course.

surgical treatment is recommended. Surgery is
crucial in SCI patients, particularly bony
decompression because of its remarkable
curative effect. Commonly used methods
include the anterior approach (ACDF/ACCF),
posterior approach (laminectomy/laminoplasty),
and
combined
anterior
and
posterior
approaches [90, 91]. The goal of surgery is to
remove spinal canal compression directly or
indirectly. The approach is selected based on
preoperative CT and MRI [33, 92]. These
imaging modalities demonstrate fracture
characteristics, position of the injured disc
compressing the spinal cord, and spinal stability
and structure [33, 88, 89, 93]. The role of the
dura mater in SCI should not be ignored [94, 95].
Numerous studies have shown that surgical
durotomy can significantly reduce intraspinal
pressure [68–72, 96, 97]. In patients with
elevated intraspinal pressure, anterior decom‐
pression alone is not sufficient and extensive
posterior laminectomy combined with duro‐
tomy or even myelotomy is required for
decompression [68–72, 94–100]. Therefore, in the
presence of spinal cord compression and only
local edema, anterior or posterior local
decompression is feasible. Extensive laminec‐
tomy plus durotomy for decompression is
required in cases with extensive spinal cord
edema. In the presence of spinal cord hematoma
or necrotic foci, additional myelotomy can be
considered.

Operative methods

Durotomy and duroplasty

Surgical treatment is mainly determined using
the Sub‐axial Injury Classification and Severity
Scale, and Thoracolumbar Injury Classification
and Severity Score (TLICS) developed by the
Spine Trauma Study Group [88, 89]. Conser‐
vative treatment is recommended for scores ≤ 3.
For a score of 4, either surgery or conservative
treatment can be selected. For scores ≥ 5,

Indications for durotomy mainly include the
presence of extensive spinal edema (more than
two segments) or disrupted local cerebrospinal
fluid (CSF) circulation on MRI in AIS grades
A–C. Intraoperative absence of CSF pulsations
after laminectomy suggests the need for surgical
durotomy. However, it is not recommended in
patients with AIS grade of D or E, or those with

Surgical window
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localized edema on MRI [68, 69, 97]. Durotomy
is associated with risk of CSF leakage and
meningitis, so surgeons should weigh the
potential benefits with the risks of longer
operation time and other complications when
selecting treatment [98]. Durotomy with
preservation of the integrity of the arachnoid
membrane can theoretically reduce most of the
intraspinal pressure without causing CSF
leakage and entrance of inflammatory factors
into the CSF and spinal cord [69]. This method
can be used in patients with spinal cord edema
without significant subarachnoid hemorrhage
after intraoperative durotomy.
Myelotomy
For patients with severe spinal cord contusion
or extensive hematoma in the spinal cord,
myelotomy can be selected. In theory,
myelotomy can prevent further expansion of
secondary injury and relieve the state of high
intraspinal pressure [94, 97, 100]. Although
several clinical studies have reported neuro‐
logical improvement in acute SCI patients who
underwent myelotomy [5, 99], prospective
randomized controlled clinical trials to fully
evaluate it have not been conducted. A
meta‐analysis of data derived from four
independent prospective multicenter data
sources showed that surgical decompression
within 24 h of acute SCI was associated with
improved sensorimotor recovery [100].
The operative method of intramedullary
decompression should be considered according
to injury severity, imaging results, and
intraoperative findings. For patients with
limited compression, anterior discectomy or
laminoplasty can be performed. In patients with
severe spinal cord contusion and/or hemorrhage,
myelotomy to clear the hematoma can be
considered if hematoma is found after
durotomy [68–72, 94–101].
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Since complete transection of the spinal cord
is rare in clinical setting and in order to avoid
iatrogenic injury, microscope assisted surgery
combined with the findings of CT and MRI is
necessary for intramedullary decompression in
order to preserve the living axons of patients
with neurological impairment [101]. The 4 types
of SCI and their corresponding surgical
interventions are presented below:
a) In type I, arachnoid adhesions,
disappearance of spinal cord pulsations,
obstruction of CSF, and pale swelling of the
spinal cord are present. Interventions include
release of adhesions and restoration of CSF flow
and spinal cord pulsations.
b) In type II, intramedullary hematoma and
bone fragments are present. Interventions
include removal of hematoma and bone
fragments and spinal cord exploration.
c) In type III, the SCI is partial. Once the dura
mater is opened, liquefied tissue may emerge.
Interventions include exploring the injured area,
removing necrotic tissue, and gently washing
the area with normal saline.
d) In type IV, intramedullary softening is
present. Interventions include a 0.3–0.5 cm
longitudinal myelotomy in the softened area,
removal of softened tissue, and gently washing
the cavity with normal saline.
The boundary between the contused spinal
cord and normal spinal cord is not clear in the
early stage, so the scope of intramedullary
decompression should be limited [101].
Pediatric SCI without radiographic abnormality
(usually caused by backbends during dancing in
China), acute hyperextension myelopathy, and
surfer’s myelopathy are often characterized by
spinal venous hypertension and SCCS or
SCImH [25, 73]. Early decompression is
recommended in these patients. However, the
time threshold and method of early decompres‐
sion remain controversial and need to be
Journal of Neurorestoratology
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examined in large randomized controlled trials
[72, 74–87].

tion and inhibition and are currently being
studied [101, 109, 110].

2.4.5

2.4.7

Cell therapy

Neurorestorative mechanisms targeted in SCI
cell therapy include axon regeneration and
remyelination, neuroplasticity, neuroprotection,
neural regulation, neural structure repair,
regulation of inflammation and immune
responses, neurogenesis, angiogenesis, reduc‐
tion of scar and cavity formation, and cell
substitution [101, 102]. The few clinical trials of
cell therapy for acute or subacute SCI have
shown both positive [103] and negative
outcomes [104]. Acute SCI results in obvious
edema and inflammation in the damaged area
and early cell injection may exacerbate injury;
therefore, direct cell transplantation cell is not
recommended in the acute phase. Intrathecal or
intravenous injection of mesenchymal stromal
cells can be considered to improve systemic or
local inflammation [105].
2.4.6

Rehabilitation

Rehabilitation training can reduce the incidence
of pressure sores, deep vein thrombosis, and
other
complications,
and
can
restore
neurological function [111]. If the patientʹs
condition allows, rehabilitation can be started
with head, neck, and lumbar back supports after
surgery. The main principle of rehabilitation is
active movement to target strengthening, which
helps patients to maximize recovery of
neurological function [112]. Use of an
exoskeleton robot in rehabilitation can maintain
and extend motor function in the recovery
period after SCI [113].
Early occupational and physical therapy is
important after SCI. Reintegration of patients
with SCI through work [114]. Early
rehabilitation training should include physical
and occupational therapy as well as
neuroelectric stimulation [115].

Electrical stimulation therapy

The nervous system relies on electrical signals
for information transmission and local electrical
stimulation can improve and induce axon
regrowth [101, 106–108]. Four categories of
electrical stimulation can be used [101]. First,
neuromuscular
electrical
stimulation
is
generally used initially, which can delay loss of
muscle mass. The second is the regulation of
electrical stimulation in paralyzed patients. The
third is functional electrical stimulation of
peripheral neural structures and the spinal cord.
This method appears promising but it is still
being studied. The fourth is comprehensive
physical,
medical,
and
neuroelectrophy‐
siological interventions combined with various
neurobiological stimulations to promote SCI
motor control. These methods can effectively
adjust neurological function through stimula‐

2.4.8

Complications and comorbidity management

Hypotension
After SCI, the sympathetic nerves below the
injured level are inhibited, which results in
reduced heart rate and dilation of peripheral
blood vessels, causing susceptibility to
hypotension and shock [116]. The blood supply
of the spinal cord is segmentally distributed and
has little collateral flow; therefore, its ability to
compensate for ischemia is poor [117].
Hypotension after SCI can lead to insufficient
spinal cord perfusion. Several studies have
shown that the maintenance of mean arterial
pressure (MAP) > 85–90 mmHg is beneficial in
SCI patients [118–120]. The 2013 AANS/CNS
guidelines recommend that the MAP be
maintained at 85–90 mmHg for 5 to 7 days [50].
Appropriate fluid supplementation and volume
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expansion or administration of noradrenaline
can improve local spinal cord perfusion
pressure after SCI and relieve spinal cord
ischemia [121, 122].
Hyponatremia
Hyponatremia is a common complication of
cervical SCI. For mild hyponatremia, fluid
intake should be limited and a high salt diet
administered while closely monitoring blood
sodium concentration. For moderate to severe
dilutional hyponatremia, additional sodium
supplementation
may
be
needed.
For
hypovolemic hyponatremia, both volume
expansion and sodium supplementation should
be administered at the same time [67, 123, 124].
Deep vein thrombosis
The reported incidence of deep vein
thrombosis after SCI ranges between 16.3% and
79% [67, 101] but large‐scale epidemiological
data is lacking. Low molecular weight heparin
combined
with
physical
methods
is
recommended for prevention. Routine use of
inferior vena cava filters is not [67, 71, 125].
Respiratory complications
Respiratory complications such as respiratory
failure, repeated pneumonia, atelectasis, and
pleural effusion are the main causes of death in
SCI patients [1–4, 39, 126]. SCI above C4 may
cause respiratory muscle paralysis and
weakened or absent cough reflex, which can
result in breathing and sputum discharge
difficulties and aggravate lung infection.
Tracheotomy is occasionally needed to facilitate
mechanical ventilation and sputum suctioning.
Proper posture can help prevent or reduce
respiratory tract infection: patients should be
encouraged to sit or raise the head of the bed as
early as possible. After raising the head of the
bed, the patient should be closely monitored for
postural hypotension [127, 128].

3

Intermediate and chronic SCI stages

3.1

Chronic evaluation

Fourteen days to 6 months after SCI is
considered the intermediate stage, and after 6
months is considered chronic [14, 15, 101].
Neurological status, spinal alignment and
stability, and spinal cord lesions should be
evaluated in these stages. Comprehensive
assessment of local and systemic conditions is
necessary to develop the optimal treatment plan.
3.2

Examination

Neurological function can be assessed by the
ASIA neurological score [18, 20]. Quality of
daily life should be evaluated by the
International Association of Neurorestoratology
SCI Functional Rating Scale [14, 101]. MRI can
show spinal cord status and evaluate spinal cord
compression, atrophy, softening, and develop‐
ment of cysts, syringomyelia, and scar. Electro‐
physiological examination using somatosensory
evoked potentials and electromyography can
evaluate
sensory
and
motor
function,
respectively [14, 101].
3.3

Diagnosis

The clinical diagnosis of intermediate and
chronic SCI includes determining the level and
severity of injury, quality of life, and any
remaining spinal cord compression [21–25, 28].
Neurophysiological examination and MRI may
assist in understanding structural abnormalities
and assessing motor and sensory function
[23–25, 28].
3.4
3.4.1

Treatments
Decompressive surgery

For patients with intermediate and chronic SCI
and severe spinal cord compression, surgical
decompression may promote neurological
Journal of Neurorestoratology
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recovery.
3.4.2

Nerve bridging

Nerve bridging may also restore some
neurologic function in patients with complete
chronic SCI [129, 130]. There are three main
methods:
a) A peripheral nerve (such as the accessory or
an intercostal nerve) above the injury is used to
bridge to a nerve root or peripheral nerve
innervating a paralyzed muscle below the
injured level [131, 132].
b) Ventral roots are removed from L5 or S1
above the injured level and connected below the
injured level to the S2 or S3 ventral roots that
innervate the bladder [133–137].
c) A peripheral nerve is resected and inserted
into the ventral tract of the thoracic spinal cord
(corticospinal tract) for 4–5 mm and the distal
end of the nerve is connected to a neuromus‐
cular junction in a lower limb muscle [138].
Recent clinical reports have described the role
of these methods in neurological function
recovery in patients with SCI [139–141].
3.4.3

Electrical stimulation

Epidural stimulation training can activate nerve
circuits and promote nerve remodeling and
functional recovery in patients with complete
SCI [142]. Transcranial electrical stimulation can
effectively treat neuropathic pain after chronic
SCI [143]. Functional electrical stimulation of
permanently denervated muscle is also effective
and can preserve muscle quality and function
[144]. In addition, electrical stimulation can
improve neuroplasticity and reduce systemic
complications [145, 146] and improve pain relief,
trunk stability, and motor function [147–149].
Use of a brain–computer interface and artificial
nerve prostheses can help paralyzed patients
carry out activities of daily living and promote
neural remodeling [150–152]. Rehabilitation
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therapy using an exoskeleton robot has been
shown effective in gait rehabilitation, injury
plane decline, and improving spasms [152–154].
3.4.4

Cell therapy

Cell transplantation is an important treatment
for patients with intermediate and chronic SCI.
Several cell types have been found suitable for
transplantation, including olfactory ensheathing
cells, mesenchymal stromal cells, peripheral
blood mononuclear cells, bone marrow and
umbilical

cord

blood

cells,

bone

marrow

hematopoietic stem cells, Schwann cells, and
embryonic stem cells [100, 101, 155–174].
Transplantation of cells into the spinal cord
parenchyma through intravascular infusion,
intrathecal or intralesional injection, or multi‐
channel

administration

can

improve

both

neurological function and quality of life, with
most subjects experiencing both sensory and
motor function recovery [155–174]. However, a
few patients experience no effect [175, 176].
Recent studies have reported spinal cord
resection after acute and chronic complete SCI
and

replacing

the

area

with

a

neural

regeneration scaffold and umbilical cord blood
stromal cells [177, 178]. However, this remains
experimental and is not recommended, as
patients with complete SCI still have the
potential to recover some function using the
strategies mentioned above. Complete removal
of the spinal cord precludes the chance for
patients to spontaneously restore neurological
function in the acute and subacute stages of SCI.
Furthermore, it precludes the use of neurores‐
torative treatments in the chronic stage [179].
3.4.5

Comprehensive treatment

The clinical effect of a single neurorestorative
treatment is limited. However, comprehensive
application of several treatments is expected to
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achieve greater neurological function recovery.
Options include cell transplantation, nerve
bridging, electrical stimulation, and neuroreha‐
bilitation [112, 179–183], as well as brain–
computer interface gait training programs,
which can partially restore walking ability [184].
Implanted electrode stimulation can strengthen
neural rehabilitation and result in partial
recovery of standing and walking ability in
patients with chronic complete SCI [185, 186].
The neural and skeletal systems form a
neuro–osteogenic network, which is important
to maintain skeletal health [187]. In SCI, there is
interruption of the ascending and descending
neural tracts that connect the brain to the
sensory and autonomic innervation of bone.
Neurogenic osteoporosis after SCI is strikingly
severe [188]. Immobilization, bone denervation,
and hormonal and metabolic changes contribute
to SCI‐induced bone loss [189]. Approximately
one‐half of SCI patients sustain a long bone
fracture after injury [188]. Furthermore,
neurogenic osteoporosis after SCI causes
difficulty in bone healing after fracture [187].
However, at present, there are no evidence‐
based recommendations regarding prevention
and treatment of osteoporosis after SCI
[188–190]. Nonetheless, comprehensive neur‐
orestorative strategies may provide some benefit
in treating neurogenic osteoporosis, maintaining
skeletal health, and promoting fracture healing.

revisions and updates will be provided as new
evidence develops.
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